Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Sep;74(9):1188–1199. doi: 10.1136/jnnp.74.9.1188

Mitochondria

P Chinnery 1, E Schon 1
PMCID: PMC1738655  PMID: 12933917

Full Text

The Full Text of this article is available as a PDF (535.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. 't Hart L. M., Jansen J. J., Lemkes H. H., de Knijff P., Maassen J. A. Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging. Hum Mutat. 1996;7(3):193–197. doi: 10.1002/(SICI)1098-1004(1996)7:3<193::AID-HUMU2>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  2. Agostino Alessandro, Invernizzi Federica, Tiveron Cecilia, Fagiolari Gigliola, Prelle Alessandro, Lamantea Eleonora, Giavazzi Alessio, Battaglia Giorgio, Tatangelo Laura, Tiranti Valeria. Constitutive knockout of Surf1 is associated with high embryonic lethality, mitochondrial disease and cytochrome c oxidase deficiency in mice. Hum Mol Genet. 2003 Feb 15;12(4):399–413. doi: 10.1093/hmg/ddg038. [DOI] [PubMed] [Google Scholar]
  3. Alexander C., Votruba M., Pesch U. E., Thiselton D. L., Mayer S., Moore A., Rodriguez M., Kellner U., Leo-Kottler B., Auburger G. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000 Oct;26(2):211–215. doi: 10.1038/79944. [DOI] [PubMed] [Google Scholar]
  4. Anderson S., Bankier A. T., Barrell B. G., de Bruijn M. H., Coulson A. R., Drouin J., Eperon I. C., Nierlich D. P., Roe B. A., Sanger F. Sequence and organization of the human mitochondrial genome. Nature. 1981 Apr 9;290(5806):457–465. doi: 10.1038/290457a0. [DOI] [PubMed] [Google Scholar]
  5. Argov Z., Bank W. J. Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders. Ann Neurol. 1991 Jul;30(1):90–97. doi: 10.1002/ana.410300116. [DOI] [PubMed] [Google Scholar]
  6. Battersby B. J., Shoubridge E. A. Selection of a mtDNA sequence variant in hepatocytes of heteroplasmic mice is not due to differences in respiratory chain function or efficiency of replication. Hum Mol Genet. 2001 Oct 15;10(22):2469–2479. doi: 10.1093/hmg/10.22.2469. [DOI] [PubMed] [Google Scholar]
  7. Battersby Brendan J., Loredo-Osti J. C., Shoubridge Eric A. Nuclear genetic control of mitochondrial DNA segregation. Nat Genet. 2003 Jan 21;33(2):183–186. doi: 10.1038/ng1073. [DOI] [PubMed] [Google Scholar]
  8. Birky C. W., Jr The inheritance of genes in mitochondria and chloroplasts: laws, mechanisms, and models. Annu Rev Genet. 2001;35:125–148. doi: 10.1146/annurev.genet.35.102401.090231. [DOI] [PubMed] [Google Scholar]
  9. Blier P. U., Dufresne F., Burton R. S. Natural selection and the evolution of mtDNA-encoded peptides: evidence for intergenomic co-adaptation. Trends Genet. 2001 Jul;17(7):400–406. doi: 10.1016/s0168-9525(01)02338-1. [DOI] [PubMed] [Google Scholar]
  10. Bogenhagen D., Clayton D. A. Mouse L cell mitochondrial DNA molecules are selected randomly for replication throughout the cell cycle. Cell. 1977 Aug;11(4):719–727. doi: 10.1016/0092-8674(77)90286-0. [DOI] [PubMed] [Google Scholar]
  11. Bu X. D., Rotter J. I. X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8198–8202. doi: 10.1073/pnas.88.18.8198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Casari G., De Fusco M., Ciarmatori S., Zeviani M., Mora M., Fernandez P., De Michele G., Filla A., Cocozza S., Marconi R. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell. 1998 Jun 12;93(6):973–983. doi: 10.1016/s0092-8674(00)81203-9. [DOI] [PubMed] [Google Scholar]
  13. Chalmers R. M., Davis M. B., Sweeney M. G., Wood N. W., Harding A. E. Evidence against an X-linked visual loss susceptibility locus in Leber hereditary optic neuropathy. Am J Hum Genet. 1996 Jul;59(1):103–108. [PMC free article] [PubMed] [Google Scholar]
  14. Chinnery P. F., Howell N., Andrews R. M., Turnbull D. M. Clinical mitochondrial genetics. J Med Genet. 1999 Jun;36(6):425–436. [PMC free article] [PubMed] [Google Scholar]
  15. Chinnery P. F., Howell N., Lightowlers R. N., Turnbull D. M. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain. 1998 Oct;121(Pt 10):1889–1894. doi: 10.1093/brain/121.10.1889. [DOI] [PubMed] [Google Scholar]
  16. Chinnery P. F., Howell N., Lightowlers R. N., Turnbull D. M. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain. 1997 Oct;120(Pt 10):1713–1721. doi: 10.1093/brain/120.10.1713. [DOI] [PubMed] [Google Scholar]
  17. Chinnery P. F., Johnson M. A., Wardell T. M., Singh-Kler R., Hayes C., Brown D. T., Taylor R. W., Bindoff L. A., Turnbull D. M. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol. 2000 Aug;48(2):188–193. [PubMed] [Google Scholar]
  18. Chinnery P. F., Samuels D. C. Relaxed replication of mtDNA: A model with implications for the expression of disease. Am J Hum Genet. 1999 Apr;64(4):1158–1165. doi: 10.1086/302311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chinnery P. F., Taylor R. W., Diekert K., Lill R., Turnbull D. M., Lightowlers R. N. Peptide nucleic acid delivery to human mitochondria. Gene Ther. 1999 Dec;6(12):1919–1928. doi: 10.1038/sj.gt.3301061. [DOI] [PubMed] [Google Scholar]
  20. Chinnery P. F., Thorburn D. R., Samuels D. C., White S. L., Dahl H. M., Turnbull D. M., Lightowlers R. N., Howell N. The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both? Trends Genet. 2000 Nov;16(11):500–505. doi: 10.1016/s0168-9525(00)02120-x. [DOI] [PubMed] [Google Scholar]
  21. Chinnery P. F., Turnbull D. M. Epidemiology and treatment of mitochondrial disorders. Am J Med Genet. 2001 Spring;106(1):94–101. doi: 10.1002/ajmg.1426. [DOI] [PubMed] [Google Scholar]
  22. Chinnery P. F., Turnbull D. M., Walls T. J., Reading P. J. Recurrent strokes in a 34-year-old man. Lancet. 1997 Aug 23;350(9077):560–560. doi: 10.1016/s0140-6736(97)05005-8. [DOI] [PubMed] [Google Scholar]
  23. Ciafaloni E., Ricci E., Shanske S., Moraes C. T., Silvestri G., Hirano M., Simonetti S., Angelini C., Donati M. A., Garcia C. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol. 1992 Apr;31(4):391–398. doi: 10.1002/ana.410310408. [DOI] [PubMed] [Google Scholar]
  24. Clark K. M., Bindoff L. A., Lightowlers R. N., Andrews R. M., Griffiths P. G., Johnson M. A., Brierley E. J., Turnbull D. M. Reversal of a mitochondrial DNA defect in human skeletal muscle. Nat Genet. 1997 Jul;16(3):222–224. doi: 10.1038/ng0797-222. [DOI] [PubMed] [Google Scholar]
  25. DiMauro S. Mitochondrial encephalomyopathies: back to Mendelian genetics. Ann Neurol. 1999 Jun;45(6):693–694. doi: 10.1002/1531-8249(199906)45:6<693::aid-ana2>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  26. DiMauro S., Schon E. A. Mitochondrial DNA mutations in human disease. Am J Med Genet. 2001 Spring;106(1):18–26. doi: 10.1002/ajmg.1392. [DOI] [PubMed] [Google Scholar]
  27. Dubeau F., De Stefano N., Zifkin B. G., Arnold D. L., Shoubridge E. A. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Ann Neurol. 2000 Feb;47(2):179–185. [PubMed] [Google Scholar]
  28. ENGEL W. K., CUNNINGHAM G. G. RAPID EXAMINATION OF MUSCLE TISSUE. AN IMPROVED TRICHROME METHOD FOR FRESH-FROZEN BIOPSY SECTIONS. Neurology. 1963 Nov;13:919–923. doi: 10.1212/wnl.13.11.919. [DOI] [PubMed] [Google Scholar]
  29. Falkenberg Maria, Gaspari Martina, Rantanen Anja, Trifunovic Aleksandra, Larsson Nils-Göran, Gustafsson Claes M. Mitochondrial transcription factors B1 and B2 activate transcription of human mtDNA. Nat Genet. 2002 Jun 17;31(3):289–294. doi: 10.1038/ng909. [DOI] [PubMed] [Google Scholar]
  30. Fu K., Hartlen R., Johns T., Genge A., Karpati G., Shoubridge E. A. A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy. Hum Mol Genet. 1996 Nov;5(11):1835–1840. doi: 10.1093/hmg/5.11.1835. [DOI] [PubMed] [Google Scholar]
  31. Giles R. E., Blanc H., Cann H. M., Wallace D. C. Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6715–6719. doi: 10.1073/pnas.77.11.6715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Graham B. H., Waymire K. G., Cottrell B., Trounce I. A., MacGregor G. R., Wallace D. C. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet. 1997 Jul;16(3):226–234. doi: 10.1038/ng0797-226. [DOI] [PubMed] [Google Scholar]
  33. Haraguchi Misako, Tsujimoto Hiroaki, Fukushima Masakazu, Higuchi Itsuro, Kuribayashi Hideto, Utsumi Hideo, Nakayama Atsuo, Hashizume Yoshio, Hirato Junko, Yoshida Hiroki. Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice. Mol Cell Biol. 2002 Jul;22(14):5212–5221. doi: 10.1128/MCB.22.14.5212-5221.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Hayashi J., Ohta S., Kikuchi A., Takemitsu M., Goto Y., Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10614–10618. doi: 10.1073/pnas.88.23.10614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Holt I. J., Harding A. E., Morgan-Hughes J. A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988 Feb 25;331(6158):717–719. doi: 10.1038/331717a0. [DOI] [PubMed] [Google Scholar]
  36. Holt I. J., Harding A. E., Petty R. K., Morgan-Hughes J. A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet. 1990 Mar;46(3):428–433. [PMC free article] [PubMed] [Google Scholar]
  37. Howell N., Kubacka I., Halvorson S., Howell B., McCullough D. A., Mackey D. Phylogenetic analysis of the mitochondrial genomes from Leber hereditary optic neuropathy pedigrees. Genetics. 1995 May;140(1):285–302. doi: 10.1093/genetics/140.1.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Howell N. Leber hereditary optic neuropathy: mitochondrial mutations and degeneration of the optic nerve. Vision Res. 1997 Dec;37(24):3495–3507. doi: 10.1016/S0042-6989(96)00167-8. [DOI] [PubMed] [Google Scholar]
  39. Inoue K., Nakada K., Ogura A., Isobe K., Goto Y., Nonaka I., Hayashi J. I. Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat Genet. 2000 Oct;26(2):176–181. doi: 10.1038/82826. [DOI] [PubMed] [Google Scholar]
  40. Jenuth J. P., Peterson A. C., Fu K., Shoubridge E. A. Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nat Genet. 1996 Oct;14(2):146–151. doi: 10.1038/ng1096-146. [DOI] [PubMed] [Google Scholar]
  41. Jenuth J. P., Peterson A. C., Shoubridge E. A. Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice. Nat Genet. 1997 May;16(1):93–95. doi: 10.1038/ng0597-93. [DOI] [PubMed] [Google Scholar]
  42. Johnson K. R., Zheng Q. Y., Bykhovskaya Y., Spirina O., Fischel-Ghodsian N. A nuclear-mitochondrial DNA interaction affecting hearing impairment in mice. Nat Genet. 2001 Feb;27(2):191–194. doi: 10.1038/84831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Johnson M. A., Bindoff L. A., Turnbull D. M. Cytochrome c oxidase activity in single muscle fibers: assay techniques and diagnostic applications. Ann Neurol. 1993 Jan;33(1):28–35. doi: 10.1002/ana.410330106. [DOI] [PubMed] [Google Scholar]
  44. Kaukonen J., Juselius J. K., Tiranti V., Kyttälä A., Zeviani M., Comi G. P., Keränen S., Peltonen L., Suomalainen A. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science. 2000 Aug 4;289(5480):782–785. doi: 10.1126/science.289.5480.782. [DOI] [PubMed] [Google Scholar]
  45. Kerrison J. B., Miller N. R., Hsu F., Beaty T. H., Maumenee I. H., Smith K. H., Savino P. J., Stone E. M., Newman N. J. A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol. 2000 Dec;130(6):803–812. doi: 10.1016/s0002-9394(00)00603-6. [DOI] [PubMed] [Google Scholar]
  46. King M. P., Attardi G. Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNA. Cell. 1988 Mar 25;52(6):811–819. doi: 10.1016/0092-8674(88)90423-0. [DOI] [PubMed] [Google Scholar]
  47. LUFT R., IKKOS D., PALMIERI G., ERNSTER L., AFZELIUS B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest. 1962 Sep;41:1776–1804. doi: 10.1172/JCI104637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Larsson N. G., Rustin P. Animal models for respiratory chain disease. Trends Mol Med. 2001 Dec;7(12):578–581. doi: 10.1016/s1471-4914(01)02167-0. [DOI] [PubMed] [Google Scholar]
  49. Larsson N. G., Wang J., Wilhelmsson H., Oldfors A., Rustin P., Lewandoski M., Barsh G. S., Clayton D. A. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet. 1998 Mar;18(3):231–236. doi: 10.1038/ng0398-231. [DOI] [PubMed] [Google Scholar]
  50. Leonard J. V., Schapira A. H. Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet. 2000 Jan 22;355(9200):299–304. doi: 10.1016/s0140-6736(99)05225-3. [DOI] [PubMed] [Google Scholar]
  51. Leonard J. V., Schapira A. H. Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet. 2000 Jan 29;355(9201):389–394. doi: 10.1016/s0140-6736(99)05226-5. [DOI] [PubMed] [Google Scholar]
  52. Li Y., Huang T. T., Carlson E. J., Melov S., Ursell P. C., Olson J. L., Noble L. J., Yoshimura M. P., Berger C., Chan P. H. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995 Dec;11(4):376–381. doi: 10.1038/ng1295-376. [DOI] [PubMed] [Google Scholar]
  53. Lutsenko S., Cooper M. J. Localization of the Wilson's disease protein product to mitochondria. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6004–6009. doi: 10.1073/pnas.95.11.6004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Mackey D. A., Oostra R. J., Rosenberg T., Nikoskelainen E., Bronte-Stewart J., Poulton J., Harding A. E., Govan G., Bolhuis P. A., Norby S. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet. 1996 Aug;59(2):481–485. [PMC free article] [PubMed] [Google Scholar]
  55. Mandel H., Szargel R., Labay V., Elpeleg O., Saada A., Shalata A., Anbinder Y., Berkowitz D., Hartman C., Barak M. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet. 2001 Nov;29(3):337–341. doi: 10.1038/ng746. [DOI] [PubMed] [Google Scholar]
  56. Manfredi G., Gupta N., Vazquez-Memije M. E., Sadlock J. E., Spinazzola A., De Vivo D. C., Schon E. A. Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene. J Biol Chem. 1999 Apr 2;274(14):9386–9391. doi: 10.1074/jbc.274.14.9386. [DOI] [PubMed] [Google Scholar]
  57. Meirelles F. V., Smith L. C. Mitochondrial genotype segregation in a mouse heteroplasmic lineage produced by embryonic karyoplast transplantation. Genetics. 1997 Feb;145(2):445–451. doi: 10.1093/genetics/145.2.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Mishmar Dan, Ruiz-Pesini Eduardo, Golik Pawel, Macaulay Vincent, Clark Andrew G., Hosseini Seyed, Brandon Martin, Easley Kirk, Chen Estella, Brown Michael D. Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci U S A. 2002 Dec 30;100(1):171–176. doi: 10.1073/pnas.0136972100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Moraes C. T., Ciacci F., Silvestri G., Shanske S., Sciacco M., Hirano M., Schon E. A., Bonilla E., DiMauro S. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord. 1993 Jan;3(1):43–50. doi: 10.1016/0960-8966(93)90040-q. [DOI] [PubMed] [Google Scholar]
  60. Moraes C. T., Schon E. A. Detection and analysis of mitochondrial DNA and RNA in muscle by in situ hybridization and single-fiber PCR. Methods Enzymol. 1996;264:522–540. doi: 10.1016/s0076-6879(96)64046-4. [DOI] [PubMed] [Google Scholar]
  61. NASS S., NASS M. M. INTRAMITOCHONDRIAL FIBERS WITH DNA CHARACTERISTICS. II. ENZYMATIC AND OTHER HYDROLYTIC TREATMENTS. J Cell Biol. 1963 Dec;19:613–629. doi: 10.1083/jcb.19.3.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Newman N. J., Lott M. T., Wallace D. C. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol. 1991 Jun 15;111(6):750–762. doi: 10.1016/s0002-9394(14)76784-4. [DOI] [PubMed] [Google Scholar]
  63. Nishino I., Spinazzola A., Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999 Jan 29;283(5402):689–692. doi: 10.1126/science.283.5402.689. [DOI] [PubMed] [Google Scholar]
  64. Old S. L., Johnson M. A. Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J. 1989 Sep-Oct;21(9-10):545–555. doi: 10.1007/BF01753355. [DOI] [PubMed] [Google Scholar]
  65. Petty R. K., Harding A. E., Morgan-Hughes J. A. The clinical features of mitochondrial myopathy. Brain. 1986 Oct;109(Pt 5):915–938. doi: 10.1093/brain/109.5.915. [DOI] [PubMed] [Google Scholar]
  66. Poulton J., Macaulay V., Marchington D. R. Mitochondrial genetics '98 is the bottleneck cracked? Am J Hum Genet. 1998 Apr;62(4):752–757. doi: 10.1086/301811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Poulton J., Turnbull D. M. 74th ENMC international workshop: mitochondrial diseases 19-20 november 1999, Naarden, the netherlands. Neuromuscul Disord. 2000 Aug;10(6):460–462. doi: 10.1016/s0960-8966(00)00101-2. [DOI] [PubMed] [Google Scholar]
  68. Prezant T. R., Agapian J. V., Bohlman M. C., Bu X., Oztas S., Qiu W. Q., Arnos K. S., Cortopassi G. A., Jaber L., Rotter J. I. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet. 1993 Jul;4(3):289–294. doi: 10.1038/ng0793-289. [DOI] [PubMed] [Google Scholar]
  69. Reardon W., Ross R. J., Sweeney M. G., Luxon L. M., Pembrey M. E., Harding A. E., Trembath R. C. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet. 1992 Dec 5;340(8832):1376–1379. doi: 10.1016/0140-6736(92)92560-3. [DOI] [PubMed] [Google Scholar]
  70. Riordan-Eva P., Sanders M. D., Govan G. G., Sweeney M. G., Da Costa J., Harding A. E. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain. 1995 Apr;118(Pt 2):319–337. doi: 10.1093/brain/118.2.319. [DOI] [PubMed] [Google Scholar]
  71. Rötig A., de Lonlay P., Chretien D., Foury F., Koenig M., Sidi D., Munnich A., Rustin P. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997 Oct;17(2):215–217. doi: 10.1038/ng1097-215. [DOI] [PubMed] [Google Scholar]
  72. Saada A., Shaag A., Mandel H., Nevo Y., Eriksson S., Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet. 2001 Nov;29(3):342–344. doi: 10.1038/ng751. [DOI] [PubMed] [Google Scholar]
  73. Saadati H. G., Hsu H. Y., Heller K. B., Sadun A. A. A histopathologic and morphometric differentiation of nerves in optic nerve hypoplasia and Leber hereditary optic neuropathy. Arch Ophthalmol. 1998 Jul;116(7):911–916. doi: 10.1001/archopht.116.7.911. [DOI] [PubMed] [Google Scholar]
  74. Sasarman Florin, Karpati George, Shoubridge Eric A. Nuclear genetic control of mitochondrial translation in skeletal muscle revealed in patients with mitochondrial myopathy. Hum Mol Genet. 2002 Jul 1;11(14):1669–1681. doi: 10.1093/hmg/11.14.1669. [DOI] [PubMed] [Google Scholar]
  75. Schon E. A., Bonilla E., DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr. 1997 Apr;29(2):131–149. doi: 10.1023/a:1022685929755. [DOI] [PubMed] [Google Scholar]
  76. Schwartz Marianne, Vissing John. Paternal inheritance of mitochondrial DNA. N Engl J Med. 2002 Aug 22;347(8):576–580. doi: 10.1056/NEJMoa020350. [DOI] [PubMed] [Google Scholar]
  77. Seibel P., Trappe J., Villani G., Klopstock T., Papa S., Reichmann H. Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res. 1995 Jan 11;23(1):10–17. doi: 10.1093/nar/23.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Shoubridge E. A. Nuclear genetic defects of oxidative phosphorylation. Hum Mol Genet. 2001 Oct 1;10(20):2277–2284. doi: 10.1093/hmg/10.20.2277. [DOI] [PubMed] [Google Scholar]
  79. Shy G. M., Gonatas N. K., Perez M. Two childhood myopathies with abnormal mitochondria. I. Megaconial myopathy. II. Pleoconial myopathy. Brain. 1966 Mar;89(1):133–158. doi: 10.1093/brain/89.1.133. [DOI] [PubMed] [Google Scholar]
  80. Silva J. P., Köhler M., Graff C., Oldfors A., Magnuson M. A., Berggren P. O., Larsson N. G. Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat Genet. 2000 Nov;26(3):336–340. doi: 10.1038/81649. [DOI] [PubMed] [Google Scholar]
  81. Sligh J. E., Levy S. E., Waymire K. G., Allard P., Dillehay D. L., Nusinowitz S., Heckenlively J. R., MacGregor G. R., Wallace D. C. Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice. Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14461–14466. doi: 10.1073/pnas.250491597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Spelbrink J. N., Li F. Y., Tiranti V., Nikali K., Yuan Q. P., Tariq M., Wanrooij S., Garrido N., Comi G., Morandi L. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet. 2001 Jul;28(3):223–231. doi: 10.1038/90058. [DOI] [PubMed] [Google Scholar]
  83. Sutovsky P., Moreno R. D., Ramalho-Santos J., Dominko T., Simerly C., Schatten G. Ubiquitin tag for sperm mitochondria. Nature. 1999 Nov 25;402(6760):371–372. doi: 10.1038/46466. [DOI] [PubMed] [Google Scholar]
  84. Taivassalo T., Fu K., Johns T., Arnold D., Karpati G., Shoubridge E. A. Gene shifting: a novel therapy for mitochondrial myopathy. Hum Mol Genet. 1999 Jun;8(6):1047–1052. doi: 10.1093/hmg/8.6.1047. [DOI] [PubMed] [Google Scholar]
  85. Taivassalo T., Matthews P. M., De Stefano N., Sripathi N., Genge A., Karpati G., Arnold D. L. Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency. Neurology. 1996 Aug;47(2):529–534. doi: 10.1212/wnl.47.2.529. [DOI] [PubMed] [Google Scholar]
  86. Taivassalo T., Shoubridge E. A., Chen J., Kennaway N. G., DiMauro S., Arnold D. L., Haller R. G. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. Ann Neurol. 2001 Aug;50(2):133–141. doi: 10.1002/ana.1050. [DOI] [PubMed] [Google Scholar]
  87. Taivassalo Tanja, Abbott Amy, Wyrick Phil, Haller Ronald G. Venous oxygen levels during aerobic forearm exercise: An index of impaired oxidative metabolism in mitochondrial myopathy. Ann Neurol. 2002 Jan;51(1):38–44. doi: 10.1002/ana.10027. [DOI] [PubMed] [Google Scholar]
  88. Taylor R. W., Chinnery P. F., Turnbull D. M., Lightowlers R. N. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet. 1997 Feb;15(2):212–215. doi: 10.1038/ng0297-212. [DOI] [PubMed] [Google Scholar]
  89. Thorburn D. R., Dahl H. H. Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options. Am J Med Genet. 2001 Spring;106(1):102–114. doi: 10.1002/ajmg.1380. [DOI] [PubMed] [Google Scholar]
  90. Tiranti V., Hoertnagel K., Carrozzo R., Galimberti C., Munaro M., Granatiero M., Zelante L., Gasparini P., Marzella R., Rocchi M. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet. 1998 Dec;63(6):1609–1621. doi: 10.1086/302150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Torroni A., Huoponen K., Francalacci P., Petrozzi M., Morelli L., Scozzari R., Obinu D., Savontaus M. L., Wallace D. C. Classification of European mtDNAs from an analysis of three European populations. Genetics. 1996 Dec;144(4):1835–1850. doi: 10.1093/genetics/144.4.1835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Torroni A., Petrozzi M., D'Urbano L., Sellitto D., Zeviani M., Carrara F., Carducci C., Leuzzi V., Carelli V., Barboni P. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet. 1997 May;60(5):1107–1121. [PMC free article] [PubMed] [Google Scholar]
  93. Tsao K., Aitken P. A., Johns D. R. Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy. Br J Ophthalmol. 1999 May;83(5):577–581. doi: 10.1136/bjo.83.5.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Van Goethem G., Dermaut B., Löfgren A., Martin J. J., Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet. 2001 Jul;28(3):211–212. doi: 10.1038/90034. [DOI] [PubMed] [Google Scholar]
  95. Wallace D. C. Mitochondrial diseases in man and mouse. Science. 1999 Mar 5;283(5407):1482–1488. doi: 10.1126/science.283.5407.1482. [DOI] [PubMed] [Google Scholar]
  96. Wallace D. C., Singh G., Lott M. T., Hodge J. A., Schurr T. G., Lezza A. M., Elsas L. J., 2nd, Nikoskelainen E. K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988 Dec 9;242(4884):1427–1430. doi: 10.1126/science.3201231. [DOI] [PubMed] [Google Scholar]
  97. Wang J., Wilhelmsson H., Graff C., Li H., Oldfors A., Rustin P., Brüning J. C., Kahn C. R., Clayton D. A., Barsh G. S. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet. 1999 Jan;21(1):133–137. doi: 10.1038/5089. [DOI] [PubMed] [Google Scholar]
  98. White S. L., Collins V. R., Wolfe R., Cleary M. A., Shanske S., DiMauro S., Dahl H. H., Thorburn D. R. Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993. Am J Hum Genet. 1999 Aug;65(2):474–482. doi: 10.1086/302488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Y-W-Man P., Griffiths P. G., Brown D. T., Howell N., Turnbull D. M., Chinnery P. F. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2002 Jan 7;72(2):333–339. doi: 10.1086/346066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. van Beekvelt M. C., van Engelen B. G., Wevers R. A., Colier W. N. Quantitative near-infrared spectroscopy discriminates between mitochondrial myopathies and normal muscle. Ann Neurol. 1999 Oct;46(4):667–670. doi: 10.1002/1531-8249(199910)46:4<667::aid-ana19>3.3.co;2-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES